Prescribing differences in family practice for diabetic patients in Germany according to statutory or private health insurance: the case of DPP-4-inhibitors and GLP-1-agonists

Table 3 Result of multivariable analysis

Covariable	Odds Ratio [95 %-CI]	Statistical Significance (p-Value)
Age in Years	0.983 [0.981, 0.985]	p < 0.0001
Sex (0: male, 1: female)	0.870 [0.826, 0.917]	p < 0.0001
Morbidity (Charlson-Index)	0.998 [0.920, 1.079]	n. s.
Health insurance (0: statutory, 1: private)	1.385 [1.240, 1.546]	p < 0.0001

ISSN: 2731-4553